---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-038648"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2026-08-17T12:35:37+00:00"
generated_at: "2026-08-17T12:40:32.886096+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INVO Fertility Q2 2026 revenue up 17% to $2.18M; net income $0.9M vs $3.6M loss

## Summary
- Revenue $2,175,485, up 17% YoY; clinic revenue $2,167,785, up 18% from $1,832,094.
- Net income $0.9M vs $(3.6)M loss; includes ~$2.5M gain on Birmingham acquisition remeasurement.
- Clinic-Level Adjusted EBITDA $333K in Q2 vs $164K in Q1; $951K for FY 2025.
- Adjusted EBITDA $(1.0)M vs $(0.6)M; cash $3.7M at June 30, 2026.
- Birmingham clinic now wholly owned after June 2026 acquisition of remaining interests.

## SEC filing metadata
- accession: 0001493152-26-038648
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2026-08-17T12:35:37+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315226038648/0001493152-26-038648-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315226038648/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-038648
- JSON: https://secwatch.observer/filing/0001493152-26-038648.json
- Plain text: https://secwatch.observer/filing/0001493152-26-038648.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.